Irvine, California 92697


Purpose:

This study evaluates theories regarding cocaine abstinence which propose that increased presynaptic and postsynaptic dopamine activity and increased serotonin activity are associated with abstinence in cocaine dependent subjects at the beginning and three to six months after a treatment program. We are using positron emission tomography (PET), Magnetic Resonance Imaging (MRI) and diffusion tensor imaging (DTI) in cortical and subcortical areas in a series of brain imaging studies testing these theories of abnormalities in the dopamine and serotonin system for cocaine addiction by examining the distribution of 18F-fallypride, 18F-altanserin, and FDG. We are evaluating genetic theories associated with cocaine addiction through the examination of genetic markers and functional genomics.


Criteria:

Inclusion Criteria: Inclusion criteria include: 1. Subjects must be male or female and English speaking. 2. Subjects must be adults with a history of diagnosis of cocaine dependence disorder (n=20) who are under supervised treatment for dependence or normal control (n=10). 3. Subjects must be between 21 to 65 years of age. Exclusion Criteria: Exclusion criteria include: 1. Suicidality or psychosis. 2. Head injury, kidney or bladder disease or any unstable or serious medical conditions. 3. Prior exposure to radiation (including diagnostic or treatment x-rays), which might cause subjects to exceed standard guidelines. 4. Unwillingness or inability to adhere to the requirements of the study. 5. Donation or large loss of blood (>400 ml) within the past month. 6. Current or very recent illnesses, painful conditions or other disorders, which in the judgment of the investigators, might invalidate the scientific goals of the study or pose undesirable difficulties or risks for subjects. 7. Pregnancy or breast feeding. 8. Individuals who would be unable to undergo a magnetic resonance imaging (MRI) scan, for example, individuals who suffer from claustrophobia, or who have metal clips in their body, metallic prostheses (i.e., replacement body parts, such as a hip joint), a pacemaker, or other pieces of metal in their body (shrapnel, metal filings, etc.).


NCT ID:

NCT00581282


Primary Contact:

Principal Investigator
Joseph C Wu, M.D.
University of California, Irvine

Joseph C Wu, M.D.
Phone: 949-824-7867
Email: jcwu@uci.edu


Backup Contact:

N/A


Location Contact:

Irvine, California 92697
United States

Joseph C Wu, M.D.
Phone: 949-824-7867
Email: jcwu@uci.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.